ArticleScientific reports2026
Different fatty acid patterns in serum in patients with various thyroid diseases.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Serum free fatty acid profiles as novel biomarkers for disease activity in Graves' orbitopathy.Journal of endocrinological investigation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Thyroid diseases and obesity are major health issues in the 21st century. While fatty acids (FAs) are known to influence various conditions, their role in thyroid disorders remains unclear. This study investigated FA profiles in patients with thyroid diseases to assess their diagnostic potential. From 891 patients treated at the Thyroid Cancer Center of the Medical University of Gdansk (2021-2024), 173 were selected for FA analysis using gas chromatography-mass spectrometry. Receiver operating characteristic (ROC) analysis evaluated the predictive value of individual FAs, and metabolite set enrichment analysis (MSEA) identified changes in FA metabolism. Results showed significant alterations in FA profiles among thyroid disease patients. Notably, levels of specific n-3 polyunsaturated FAs (ALA, EPA, DHA) were reduced in Hashimoto's thyroiditis (HT) compared to healthy controls, despite no significant change in total PUFA levels. ROC analysis highlighted certain FAs with high AUC values, especially in HT and follicular cell adenoma, indicating potential as diagnostic biomarkers. MSEA revealed disruptions in pathways related to α-linolenic and linoleic acid metabolism and β-oxidation of very long-chain FAs. These findings suggest FA profiling could support the diagnosis of thyroid disorders and offer new insights into disease-related metabolic changes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.